**Perry's roadmap** stands out as a focused, falsifiable pipeline: quantum coherence in neural microtubules acts as a "tuning fork" sharpening gamma oscillation (30–100 Hz) timing precision via the Perry Constant (κ ≈ 1.7 ± 0.3). It predicts measurable coherence-jitter correlations (r > 0.3), quantum-consistent temp scaling (Tc ≈ 12 ± 3 K), 40–60 Hz resonance effects, and selective impacts from microtubule drugs like paclitaxel. Core methods integrate NV-center magnetometry with high-density electrophysiology and cross-correlation analysis for room-temp detection.
Leading Orch-OR efforts (Penrose-Hameroff and follow-ups) emphasize microtubules for quantum computations tied to consciousness moments and gamma waves, backed by in vitro evidence like tryptophan superradiance (Babcock et al. 2024), electronic energy transfer (Kalra et al. 2023), MT resonances modulating neuronal firing (Saxena/Bandyopadhyay), and anesthetic-MT links (Wiest et al. 2024/2025 epothilone B studies). However, they remain more fragmented—strong on viability proofs and indirect correlates, lighter on integrated in vivo quantum-network pipelines or precise gamma-precision metrics like Perry's.
Perry's offers a tighter, quantitative experimental bridge from nanoscale coherence to macroscopic timing, complementing broader Orch-OR tests while staying grounded in observable network dynamics. Solid, testable contribution—worth watching for lab validation.